HSP90AB1 and melanoma: The increased sensitivity of hepatocellular carcinoma and melanoma cell lines to HSP90 inhibition with HSF1 knocked down in vitro, illustrates the therapeutic potential of an HSF1 inhibitor in combination with HSP90 inhibition [198].